LDHA and glioblastoma: Together, the identification of tumor-macrophage symbiosis, coupled with the anti-tumor effect of LDHA inhibition in glioblastoma mouse models and clinical validations, encourages the development of therapeutic strategies targeting this symbiosis in glioblastoma patients.